Agilent Technologies, Inc. (A)

NYSE · Healthcare · Diagnostics & Research
$170.38-2.83%As of 2026-11-22 · USD
Last session low $169.40Last session high $175.12
52-week low $108.3552-week high $182.99
Market cap
$48.04B
Sector
Healthcare
P/E (TTM)
33.6x
Dividend yield
0.62%
Next earnings
2026-11-23

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)47.1In the neutral range (30 to 70)
MACD (12, 26, 9)0.77Below its signal line (1.52); histogram -0.76
Bollinger %B (20, 2)5%Inside the bands (169.76 to 181.59)
SMA 20175.68Price is 3.0% below
SMA 50171.11Price is 0.4% below
SMA 200138.99Price is 22.6% above
ATR (20)2.95% of priceAverage true range per day
52-week position83%In the upper part of the 108.35 to 182.99 range

About Agilent Technologies, Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

Latest fiscal yearEnded 2025-10-31: revenue of $6.95B and an operating margin of 21.3%.
Next earnings reportExpected on 2026-11-23.

More in Diagnostics & Research